Merck Ends COVID Vaccine Program, Cites Inferior Immune Responses
Published
The drugmaker will instead focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected...
Full ArticlePublished
The drugmaker will instead focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected...
Full Article